Search
Now showing items 1-1 of 1
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
(Brac University, 2022-03)
SHP2 (Src homology-2 domain-containing protein tyrosinephosphatase-2) works as a tyrosine
phosphatase, to eliminate tyrosine phosphorylation in the non-receptor protein to link many
oncogenic signaling pathways including ...